![Inabata](https://www.pharmacompass.com/image/flap/inabata-corp-desktop-header-w26gif-37454.gif)
![Inabata](https://www.pharmacompass.com/image/flap/inabata-corp-mobile-header-w26gif-18803.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.globenewswire.com/news-release/2024/04/17/2864235/0/en/Essential-Pharma-Announces-the-Acquisition-of-Reminyl-galantamine-hydrobromide-Oral-Capsules.html
https://www.pharmacompass.com/pdf/news/aurobindo-pharmas-generic-galantamine-hydrobromide-approved-in-us-1471603723.pdf
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/anvisa+ja+aprovou+dezoito+novos+medicamentos+genericos+ineditos+em+2015